CLASS 1 RECALL - MEXILETINE HYDROCHLORIDE 50MG, 100MG AND 200MG HARD CAPSULES

Clinigen Healthcare Ltd is initiating a recall of three batches of Mexiletine hydrochloride hard capsules due to a potential risk of underdose or overdose, which could have consequences for the safety of patients.

MHRA drug alert date:  4 August 2022

MHRA drug alert link: 

https://www.gov.uk/drug-device-alerts/national-patient-safety-alert-class-1-medicines-recall-notification-recall-of-mexiletine-hydrochloride-50mg-100mg-and-200-mg-hard-capsules-clinigen-healthcare-ltd-due-to-a-potential-for-underdosing-and-slash-or-overdosing-natpsa-s?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=a1c1fa91-a26a-40a3-a473-d720cced6b0b&utm_content=immediately

Further information

For more information or stock and resupply queries, please contact Quantum Pharmaceutical +44 (0) 1207 279 400 or email enquiries@quantumpharma.co.uk

For medical information queries, please contact Clinigen Medical Information on +44 (0) 1932 824 026 or email medicalinformation@clinigengroup.com

For all other enquires place contact Clinigen Healthcare Ltd on +44 (0) 1283 494 340 or email medicineaccess@clinigengroup.com

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 Drug Caution In Use - Niquitin 14mg Clear Patch x 14

Omega Pharma Limited have identified an error relating to the product packaging. In the ‘Ingredients’ section on the base of the carton, the patch dosage is stated as providing 21mg of nicotine per day. The correct dosage is 14mg per day. The other dosage indications on the carton, the sachets, PIL and SmPC are correct. There is no issue with the product quality and the batch is not being recalled.

MHRA drug alert date: 20 July 2022

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-omega-pharma-limited-niquitin-14mg-clear-patch-14-patches-el-22-a-slash-32?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=e4ca04d0-7b49-4bf4-ac21-370254221350&utm_content=immediately

This is a caution in use only we are not accepting stock returns - if any defective stock is found it should be returned directly to the manufacturer.

Further Information

For medical information and stock control queries please contact: uklocustomerservice@perrigo.com

Class 4 Drug Caution In Use - NovoRapid FlexTouch 100 units/ml and Saxenda FlexTouch® (liraglutide) 6mg/ml

Novo Nordisk Limited would like to notify you of a defect that affects specific batches of NovoRapid FlexTouch prefilled pen device and batches of Saxenda FlexTouch prefilled pen device in the UK. The defect results in a non-functioning device where it is not possible to set a dose because the dose selector will spin freely, as such, click sounds will not be heard. Since a dose cannot be selected, the patient cannot inject a dose. A very small number of pens are affected – the average number of affected products is 2-3 pens per million pens. Based on the critical need for the products, they are not being recalled.

MHRA drug alert date: 21 July 2022

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-novo-nordisk-limited-novorapid-r-flextouch-r-100-units-slash-ml-saxenda-r-flextouch-r-liraglutide-6mg-slash-ml-el-22-a-slash-33?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=d1821ab9-5a71-4493-a0b8-973140c8ca04&utm_content=immediately

This is a caution in use only we are not accepting stock returns - if any defective stock is found it should be returned directly to Novo Nordisk Limited.

Further Information

For medical information and stock control queries please contact: Customer Care contact details +44 (0)800 023 2573 or CustomerCare@novonordisk.com

Class 2 Recall - Amiodarone Hydrochloride 50mg/ml Concentrate for Solution for Injection/Infusion

Hameln pharma ltd is initiating a recall of batch 207506 of Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion as a precautionary measure. This is due to an increased presence of visible crystalline particles within the solution, identified during ongoing re-inspection of retained samples.

MHRA drug alert date: 19 July 2022

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-hameln-pharma-ltd-amiodarone-hydrochloride-50-mg-slash-ml-concentrate-for-solution-for-injection-slash-infusion-el-22-a-slash-31?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=fa9877a9-7754-4352-bb81-906f9407cb81&utm_content=immediately

Alliance do not stock the above product so we will not be accepting Customer returns on this recall.

Further Information

For more information or supply queries, please contact or email Hameln pharma ltd customer services on +44 (0)1452 621 661 or customer.services@hameln-pharma.co.uk

For medical information queries, please contact or email Hameln pharma ltd Medicines Information on +44 (0)1452 621 661 or drug.safety@hameln-pharma.co.uk

Service Update - staying safe during extreme heat

The team at Alliance Healthcare want you and your patients to stay safe during the extreme heat.

We are doing all that we can to deliver to you while ensuring the safety of our team members and the integrity of your products.

Customers can find the latest service news on our myahportal here.

Class 4 Drug Caution In Use - Covonia Night Time Formula & Covonia Original Bronchial Balsam

Thornton & Ross have identified that the product labelling for some batches of ‘Pharmacy’ medicines do not contain the ‘P’ symbol, due to a packaging error on the bottle.

MHRA drug alert date: 14 July 2022

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-thornton-and-ross-covonia-night-time-formula-and-covonia-original-bronchial-balsam-el-22-a-slash-30?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=1610a023-5b61-41a6-a141-8768fd5f9c85&utm_content=immediately

This is a caution in use only we are not accepting stock returns.

Further Information

For medical information or stock control queries please contact : Thornton & Ross on 01484 842217 or thorntonross@medinformation.co.uk

Service disruption update - Leeds Service Centre (15 July 2022)

10:15, 15 July 2022 - for customers supplied by Leeds Service Centre only

As we start to move back to normal fridge supply, you will begin to receive some items twice daily. While we continue our work to fully resolve this issue, please transmit your fridge items by 17:30 until further notice. Supply of all other product remains unaffected and standard cut-off applies. Please contact Customer Service with any emergency requirements. Thank you for your continued cooperation. 

Northern Ireland - Tuesday 12 July 2022 Bank Holiday Opening Hours

Please note that Belfast Service Centre will be closed on Tuesday 12 July. There will be normal service provided on both Monday 11 July and Wednesday 13 July.

- Any orders placed on Monday 11 July, up to your normal evening cut off, will be delivered on the morning of Wednesday 13 July

- Orders placed up to your normal evening cut off time on Tuesday 12 July will be delivered on Wednesday afternoon

In the event of an out of hours emergency (i.e., urgent CD lines being required), please call customer service on 0330 100 0448.

Outside of normal opening hours, when you enter your account number, you will hear a message advising you of your supplying Service Centre. You will then be directed to the out-of-hours security company who will handle your call and direct it appropriately.

The previous emergency call-out numbers will no longer be in use, so please ensure you update your records with the number above to ensure there is no delay with your request.

Please note, all emergency call-outs will incur a £100 charge, plus courier charges.

Taking action to avoid disruption to service - UK Fuel Protests

Our drivers will do all they can to take alternative routes to avoid disrupting our service to you as a result of fuel protests throughout Monday 4 July.

Any unavoidable change to your deliveries as a result will be communicated using our normal channels.

Thank you for your patience while we continue to work hard to deliver to you as normal, without impact.

Company Led Recall - Linoforce granules 12 years plus

A.Vogel Ltd is recalling the above batch of Pharmacy only medicine due to a small number of packs that were inadvertently supplied to non-pharmacy retail outlets.

This recall is being issued as a company-led medicines recall as this product is only supplied to several outlets, and the manufacturer has full traceability of the onward distribution by their customers.

Remaining stock of the above batch should be quarantined and returned to the company directly.

MHRA drug alert date: 22 June 2022

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/company-led-medicines-recall-avogel-ltd-linoforce-granules-12-years-plus-thr-13668-slash-0021-clmr-22-a-slash-05?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=9a9d096a-2ab5-48fb-93c4-731c29c2c6cd&utm_content=immediately

Alliance do not stock this product and therefore we are not accepting stock returns.

For medical information enquiries, please contact:

Gillian Forrest

A..Vogel Ltd

2 Brewster Place

Irvine

Ayrshire

KA11 5DD

Email: gillian@avogel.co.uk

For stock information enquiries, please contact:

Debbie Martin

A.Vogel Ltd

2 Brewster Place

Irvine

Ayrshire

KA11 5DD

Email: debbie@avogel.co.uk

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.